Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial

2014, OCT Sub-Study Committee for the NORDIC Idiopathic Intracranial Hypertension Study Group. Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial: Part I. Quality control, comparisons and variability, Inv Ophthal Vis Sci, 55, 8173 NORDIC Idiopathic Intracranial Hypertension Study Group, 2014, The Idiopathic Intracranial Hypertension Treatment Trial: a randomized trial of acetazolamide, JAMA, 311, 1641 2014, OCT Sub-Study Committee for the NORDIC Idiopathic Intracranial Hypertension Study Group. Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial: Part II. Correlations and relationship to clinical features, Inv Ophthal Vis Sci, 55, 8180 Wang, 2012, Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography, Invest Ophthalmol Vis Sci, 53, 4069, 10.1167/iovs.12-9438 Garvin, 2008, Intraretinal layer segmentation of macular optical coherence tomography images using optimal 3-D graph search, IEEE Trans Med Imaging, 27, 1495, 10.1109/TMI.2008.923966 Frisén, 1982, Swelling of the optic nerve head: a staging scheme, J Neurol Neurosurg Psychiatr, 45, 13, 10.1136/jnnp.45.1.13 Friedman, 2014, The Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): design considerations and methods, J Neuro-Ophthalmol, 34, 107 Fischer, 2015, Methods and baseline results for the photographic reading center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT), Invest Ophthalmol Vis Sci, 56, 3292, 10.1167/iovs.15-16465 Mwanza, 2011, Cirrus optical coherence tomography normative database study group. Ability of Cirrus HD-OCT optic nerve head parameters to discriminated normal from glaucomatous eyes, Ophthalmology, 118, 241, 10.1016/j.ophtha.2010.06.036 Scott, 2010, Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale, Arch Ophthalmol, 128, 705, 10.1001/archophthalmol.2010.94 Vartin, 2012, Detection of mild papilledema using spectral domain optical coherence tomography, Br J Ophthalmol, 96, 375, 10.1136/bjo.2010.199562 Sinclair, 2012, Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension, J Neurol, 259, 1406 Skau, 2013, Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension, Graefes Arch Clin Exp Ophthalmol, 251, 567, 10.1007/s00417-012-2039-z Rebolleda, 2009, Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography, Inv Ophthalmol Vis Sci, 50, 5197, 10.1167/iovs.08-2528 Skau, 2011, Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study, J Neurol, 258, 277 Kupersmith, 1998, Effects of weight loss on the course of idiopathic intracranial hypertension in women, Neurology, 50, 1094, 10.1212/WNL.50.4.1094